Andrew D. Frutkin - Concepedia

Author

Andrew D. Frutkin

University of Washington ORCID

Also Known As

A. D. Frutkin, A.D. Frutkin, Andrew D Frutkin, Andrew D. Frutkin, Andrew Frutkin

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Washington Saint Luke's Hospital University of Missouri–Kansas City Washington University in St. Louis St. Luke's Hospital

About

Andrew D. Frutkin is an author at University of Washington specializing in medicine, cardiovascular disease, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	958
2	Cell Biology	4	4	708
3	Cellular Physiology	2	2	595
4	Health Sciences	1	1	55
5	Public Health	1	1	30

Andrew D. Frutkin

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries Mei Y. Speer, Hsueh-Ying Yang, Thea Brabb, Circulation Research Cellular PhysiologyRegenerative MedicineBone Morphogenic ProteinSkeletal MuscleCalcifying Arteries	2009	579
Bleeding in Patients Undergoing Percutaneous Coronary Intervention Sameer K. Mehta, Andrew D. Frutkin, Jason B. Lindsey, Circulation Cardiovascular Interventions	2009	297
TGF-β1 Limits Plaque Growth, Stabilizes Plaque Structure, and Prevents Aortic Dilation in Apolipoprotein E-Null Mice Andrew D. Frutkin, Goro Otsuka, April Stempien‐Otero, Arteriosclerosis Thrombosis and Vascular Biology	2009	99
Utilization of Distal Embolic Protection in Saphenous Vein Graft Interventions (An Analysis of 19,546 Patients in the American College of Cardiology–National Cardiovascular Data Registry) Sameer K. Mehta, Andrew D. Frutkin, Sarah Milford–Beland, The American Journal of Cardiology ThrombosisVenous DiseaseVenous ThrombosisCardiovascular DiseaseAmerican College	2007	89
Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1–Dependent Pathways Goro Otsuka, Ramtin Agah, Andrew D. Frutkin, Arteriosclerosis Thrombosis and Vascular Biology	2005	64
Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding. Scot A. Marsters, Andrew D. Frutkin, Nancy Simpson, Journal of Biological Chemistry ImmunologyPathologyCell DeathImmunologic MechanismLigand Binding	1992	62
Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease Marian C. Cheung, B. Greg Brown, Emily K. Larsen, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease InflammationMetabolic SyndromeThrombosisCardiovascular DiseasePhysiology	2005	55
Low Adiponectin Levels Are Associated With Atherogenic Dyslipidemia and Lipid-Rich Plaque in Nondiabetic Coronary Arteries Steven P. Marso, Sameer K. Mehta, Andrew D. Frutkin, Diabetes Care	2008	55
A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre Andrew D. Frutkin, Haikun Shi, Goro Otsuka, Journal of Molecular and Cellular Cardiology Myogenic Cell LineagesDevelopmental BiologyTissue DevelopmentCritical Developmental RoleFibroblast Growth Factor	2006	51
Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization Andrew D. Frutkin, Jason B. Lindsey, Sameer K. Mehta, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseasePatient SafetyOutcomes Research	2009	42

Page 1